2.08
price up icon9.47%   0.18
after-market アフターアワーズ: 2.04 -0.04 -1.92%
loading
前日終値:
$1.90
開ける:
$1.92
24時間の取引高:
926.34K
Relative Volume:
0.77
時価総額:
$131.58M
収益:
$139.77M
当期純損益:
$-97.62M
株価収益率:
-1.3165
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
+8.33%
1か月 パフォーマンス:
+20.23%
6か月 パフォーマンス:
+7.22%
1年 パフォーマンス:
-10.34%
1日の値動き範囲:
Value
$1.89
$2.085
1週間の範囲:
Value
$1.81
$2.085
52週間の値動き範囲:
Value
$0.9897
$2.485

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1106)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
341
Name
Twitter
@macrogenics
Name
次回の収益日
2025-03-07
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

Compare MGNX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MGNX
Macrogenics Inc
2.08 120.19M 139.77M -97.62M -61.71M -1.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.89 120.48B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.50 81.05B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
749.56 46.33B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.30 42.26B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.02 32.87B 5.36B 287.73M 924.18M 2.5229

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-17 再開されました Barclays Overweight
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
Mar 04, 2026

MGNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Mar 02, 2026

MacroGenics (MGNX) director Jay Siegel to step down after 2026 meeting - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

Whats the profit margin of MacroGenics IncEarnings Risk Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus

Feb 28, 2026
pulisher
Feb 27, 2026

MacroGenics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 27, 2026
pulisher
Feb 26, 2026

Cancer drug developer MacroGenics lines up March investor talks - Stock Titan

Feb 26, 2026
pulisher
Feb 24, 2026

Why is MacroGenics stock sinking Tuesday? - MSN

Feb 24, 2026
pulisher
Feb 24, 2026

MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates - MSN

Feb 24, 2026
pulisher
Feb 24, 2026

MacroGenics stock falls after FDA places partial clinical hold By Investing.com - Investing.com South Africa

Feb 24, 2026
pulisher
Feb 24, 2026

MacroGenics stock falls after FDA places partial clinical hold - Investing.com Nigeria

Feb 24, 2026
pulisher
Feb 24, 2026

MacroGenics (MGNX) Faces FDA Setback with Partial Hold on Lorige - GuruFocus

Feb 24, 2026
pulisher
Feb 24, 2026

MacroGenics stock drops after FDA partial hold (MGNX:NASDAQ) - Seeking Alpha

Feb 24, 2026
pulisher
Feb 24, 2026

FDA Places Partial Clinical Hold on MacroGenics Trial - TipRanks

Feb 24, 2026
pulisher
Feb 24, 2026

FDA Imposes Partial Clinical Hold on MacroGenics' (MGNX) Study - GuruFocus

Feb 24, 2026
pulisher
Feb 24, 2026

Why Is MacroGenics Stock Sinking Tuesday? - Bitget

Feb 24, 2026
pulisher
Feb 24, 2026

MacroGenics Pauses Enrollment Of Participants In LINNET Trial On FDA's Partial Clinical Hold - RTTNews

Feb 24, 2026
pulisher
Feb 23, 2026

MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study - TipRanks

Feb 23, 2026
pulisher
Feb 23, 2026

FDA halts new enrollment in MacroGenics (NASDAQ: MGNX) LINNET study - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Macrogenics announces pausing of enrollment of new study participants in Linnet trial - marketscreener.com

Feb 23, 2026
pulisher
Feb 23, 2026

MacroGenics Faces Partial Clinical Hold from FDA on LINNET Study of Lorigerlimab in Gynecologic Cancers - Quiver Quantitative

Feb 23, 2026
pulisher
Feb 23, 2026

FDA halts new enrollment in cancer trial after severe side effects - Stock Titan

Feb 23, 2026
pulisher
Feb 18, 2026

Panic Selling: Will MacroGenics Inc outperform the market in YEAR2025 Performance Recap & Weekly Setup with High ROI Potential - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 17, 2026

Armistice Capital (MGNX) discloses 6.32M shares, 9.99% stake via Master Fund - Stock Titan

Feb 17, 2026
pulisher
Feb 17, 2026

MacroGenics (NASDAQ: MGNX) SVP awarded RSUs, options and exercises units - Stock Titan

Feb 17, 2026
pulisher
Feb 17, 2026

MacroGenics (MGNX) GC awarded 150,000 options and 25,000 RSUs - Stock Titan

Feb 17, 2026
pulisher
Feb 17, 2026

Why MacroGenics Inc. stock is favored by pension fundsEarnings Beat & Accurate Entry/Exit Alerts - mfd.ru

Feb 17, 2026
pulisher
Feb 14, 2026

Income Plays: Will MacroGenics Inc outperform the market in YEARPortfolio Return Report & Capital Protection Trade Alerts - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 13, 2026

MGNX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 13, 2026
pulisher
Feb 11, 2026

Why MacroGenics Inc. stock remains a top recommendationJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Scott Koenig increases MacroGenics (MGNX) stake via 15,831 RSU conversion - Stock Titan

Feb 10, 2026
pulisher
Feb 09, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Feb 09, 2026
pulisher
Jan 31, 2026

Big Picture: Is Badger Meter Inc stock suitable for long term investing2025 Bull vs Bear & Weekly Market Pulse Alerts - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

Incyte wins EU backing for MacroGenics-partnered cancer drug in GIT indication - Seeking Alpha

Jan 30, 2026
pulisher
Jan 25, 2026

Aug Swings: Whats the fair value of Humacyte Inc Equity Warrant stockJuly 2025 Volume & Daily Chart Pattern Signals - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 24, 2026

Retail Trends: What is the next catalyst for MacroGenics IncQuarterly Profit Report & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 23, 2026

MacroGenics (NASDAQ:MGNX) Stock Crosses Below 200-Day Moving Average – Should You Sell? - Defense World

Jan 23, 2026
pulisher
Jan 23, 2026

MacroGenics (NASDAQ:MGNX) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat

Jan 23, 2026
pulisher
Jan 16, 2026

Weekly Trades: Is MacroGenics Inc attractive for institutional investorsWeekly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 15, 2026

Will MacroGenics Inc outperform the market in YEAR2025 Biggest Moves & High Conviction Trade Alerts - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Hold" by Analysts - MarketBeat

Jan 15, 2026
pulisher
Jan 14, 2026

[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.

Jan 14, 2026
pulisher
Jan 13, 2026

Is Via Renewables Inc impacted by rising ratesWeekly Trend Recap & Long-Term Growth Stock Strategies - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

MacroGenics (NASDAQ:MGNX) Stock Price Crosses Above 50 Day Moving Average – What’s Next? - Defense World

Jan 13, 2026
pulisher
Jan 12, 2026

Meme Stocks: Is MacroGenics Inc attractive for institutional investorsLayoff News & Smart Money Movement Alerts - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 08, 2026

Will MacroGenics Inc. stock benefit from green energy trendsJuly 2025 Sentiment & Consistent Income Trade Ideas - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How supply chain issues affect MacroGenics Inc. stockQuarterly Performance Summary & Weekly High Return Opportunities - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Market Leaders: How supply chain issues affect MacroGenics Inc. stockWeekly Investment Report & Step-by-Step Trade Execution Guides - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will MacroGenics Inc. stock gain from government policiesEarnings Overview Summary & Risk Controlled Swing Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Exploring Sarah Faizy's Journey in Life Sciences Leadership - BioBuzz

Jan 08, 2026
pulisher
Jan 06, 2026

How MacroGenics Inc. stock performs in rising dollar environment2026 world cup usa national team quarterfinals young talents pressing system odds analysis breakdown - ulpravda.ru

Jan 06, 2026
pulisher
Jan 06, 2026

There's No Escaping MacroGenics, Inc.'s (NASDAQ:MGNX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st

Jan 06, 2026

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$47.43
price down icon 0.11%
$29.52
price up icon 6.00%
$57.80
price up icon 15.99%
$103.80
price up icon 3.02%
$149.88
price up icon 1.96%
biotechnology ONC
$299.02
price up icon 0.67%
大文字化:     |  ボリューム (24 時間):